Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs
Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs
نویسندگان: رویا صالحی قره ورن , حامد همیشه کار , مرتضی اسکندانی , سودابه داوران
کلمات کلیدی: Cancer, dual drug delivery, nanoparticles,
stimuli-responsive, targeted delivery
نشریه: 17392 , 4 , 22 , 2014
| نویسنده ثبت کننده مقاله |
رویا صالحی قره ورن |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات کاربردی دارویی |
| کد مقاله |
71380 |
| عنوان فارسی مقاله |
Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs |
| عنوان لاتین مقاله |
Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| In this paper novel stimuli-responsive cationic mesoporous silica nanoparticles (MSNs) were
fabricated through the facile polymerization method. The synthesis process was characterized
and validated by Fourier transform infrared spectroscopy and hydrogen nuclear magnetic
resonance spectroscopy. The prepared nanoparticles were characterized using scanning
electron microscopy (SEM), Zeta potential and thermogravimetric analysis methods. SEM results
revealed the uniformity in size and shape of nanoparticles with a mean diameter of
approximately 60 nm. Two model anticancer drugs, Doxorubicin (DOX) and Methotroxate (MTX)
were loaded effectively to functionalized MSNs through electrostatic interactions. Our
developed HPLC-UV method was applied for simultaneous determination of DOX and MTX.
Modified MSNs yielded a pH and temperature-triggered release of entrapped drugs at tumor
tissue environment (lower pH and higher temperature than physiological condition). In-vitro
cytotoxicity assay showed that the blank carrier showed no cytotoxicity on both A549 and
MCF7 cells at different amounts after incubation for 72 h confirming its suitability as a drug
carrier. Multi anticancer drug-loaded MSNs, in the other hand, caused an efficient anticancer
performance verified by DAPI staining and MTT assay tests. It was concluded that our findings
may open the possibilities for cooperative thermo and pH-responsive targeted delivery of DOX
and MTX to the cancerous tissues. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 13-J Drug Target, 2014.pdf | 1398/12/16 | 2312110 | دانلود |